| Stage | MUR | % of rev | OXM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $928M | 100.00% | $394M | 100.00% | MUR ×2.35 |
| Gross profit | $739M | 79.64% | $291M | 73.82% | MUR +5.8pp |
| Operating income | $355M | 38.21% | $69M | 17.45% | MUR +20.8pp |
| Pre-tax income | $341M | 36.73% | $67M | 17.07% | MUR +19.7pp |
| Net income | $264M | 28.39% | $49M | 12.42% | MUR +16.0pp |
| Stage | MUR | OXM | Gap · A − B |
|---|---|---|---|
| Revenue | $928M100.00% | $394M100.00% | MUR ×2.35 |
| Gross profit | 79.64%$739M | 73.82%$291M | MUR +5.8pp |
| Operating income | 38.21%$355M | 17.45%$69M | MUR +20.8pp |
| Pre-tax income | 36.73%$341M | 17.07%$67M | MUR +19.7pp |
| Net income |
| 28.39%$264M |
| 12.42%$49M |
| MUR +16.0pp |
No shared counterparties.